{"id": "article-31428_0", "title": "Wyburn-Mason Syndrome -- Continuing Education Activity", "content": "Wyburn-Mason syndrome is a rare nonhereditary congenital phakomatoses which presents with multiple arteriovenous malformations that tend to be large and predominantly affect the brain, eye, and facial structures. This activity outlines the evaluation and management of patients presenting with Wyburn-Mason syndrome and highlights the role of the interprofessional team in managing the patients with this condition.", "contents": "Wyburn-Mason Syndrome -- Continuing Education Activity. Wyburn-Mason syndrome is a rare nonhereditary congenital phakomatoses which presents with multiple arteriovenous malformations that tend to be large and predominantly affect the brain, eye, and facial structures. This activity outlines the evaluation and management of patients presenting with Wyburn-Mason syndrome and highlights the role of the interprofessional team in managing the patients with this condition."}
{"id": "article-31428_1", "title": "Wyburn-Mason Syndrome -- Continuing Education Activity", "content": "Objectives: Outline the range of neurological symptoms that may be present in patients with Wyburn-Mason syndrome. Review the treatment options for arteriovenous malformations in patients with Wyburn-Mason syndrome. Describe the pathophysiology of Wyburn-Mason syndrome. Explain the importance of collaboration and coordination among the interprofessional team members to improve outcomes for patients affected by Wyburn-Mason syndrome. Access free multiple choice questions on this topic.", "contents": "Wyburn-Mason Syndrome -- Continuing Education Activity. Objectives: Outline the range of neurological symptoms that may be present in patients with Wyburn-Mason syndrome. Review the treatment options for arteriovenous malformations in patients with Wyburn-Mason syndrome. Describe the pathophysiology of Wyburn-Mason syndrome. Explain the importance of collaboration and coordination among the interprofessional team members to improve outcomes for patients affected by Wyburn-Mason syndrome. Access free multiple choice questions on this topic."}
{"id": "article-31428_2", "title": "Wyburn-Mason Syndrome -- Introduction", "content": "Wyburn-Mason syndrome\u00a0(WMS), also known as racemose angioma, is a\u00a0congenital\u00a0nonhereditary\u00a0neurocutaneous syndrome or phakomatoses\u00a0that presents with multiple arteriovenous malformations\u00a0(AVM). WMS has varied phenotypical expressions but\u00a0predominantly affects the face and brain. Bonnet, Dechaume, and Blanc\u00a0were first to recognize AVM of face, retina, and brain in the year 1937 and Wyburn-Mason\u00a0described in detail about this disease in 1943. [1] In recognition of these authors, this disease is referred to as Bonnet-Dechaume-Blanc syndrome\u00a0or Wyburn-Mason syndrome.", "contents": "Wyburn-Mason Syndrome -- Introduction. Wyburn-Mason syndrome\u00a0(WMS), also known as racemose angioma, is a\u00a0congenital\u00a0nonhereditary\u00a0neurocutaneous syndrome or phakomatoses\u00a0that presents with multiple arteriovenous malformations\u00a0(AVM). WMS has varied phenotypical expressions but\u00a0predominantly affects the face and brain. Bonnet, Dechaume, and Blanc\u00a0were first to recognize AVM of face, retina, and brain in the year 1937 and Wyburn-Mason\u00a0described in detail about this disease in 1943. [1] In recognition of these authors, this disease is referred to as Bonnet-Dechaume-Blanc syndrome\u00a0or Wyburn-Mason syndrome."}
{"id": "article-31428_3", "title": "Wyburn-Mason Syndrome -- Introduction", "content": "The AVM range in size\u00a0but often tend to be large. When involving the brain, these AVM tend to localize to the midbrain region, thus necessitating neurologic imaging to rule out life-threatening or potentially debilitating lesions in this area. The ophthalmoscopic presentation of the AVM in WMS is characteristic with dilated and tortuous vessels present over the optic disc and extending variably to the retinal periphery. \u00a0Presenting vision may range from normal to no light perception\u00a0and depends upon the associated ophthalmic complications.\u00a0Vascular malformations may be present elsewhere in the body. Wyburn-Mason syndrome does not\u00a0cause significant cutaneous manifestations, except for the rare occurrence of small facial angioma over the trigeminal region of the face. [2] [3] [4] [5] [1] [5]", "contents": "Wyburn-Mason Syndrome -- Introduction. The AVM range in size\u00a0but often tend to be large. When involving the brain, these AVM tend to localize to the midbrain region, thus necessitating neurologic imaging to rule out life-threatening or potentially debilitating lesions in this area. The ophthalmoscopic presentation of the AVM in WMS is characteristic with dilated and tortuous vessels present over the optic disc and extending variably to the retinal periphery. \u00a0Presenting vision may range from normal to no light perception\u00a0and depends upon the associated ophthalmic complications.\u00a0Vascular malformations may be present elsewhere in the body. Wyburn-Mason syndrome does not\u00a0cause significant cutaneous manifestations, except for the rare occurrence of small facial angioma over the trigeminal region of the face. [2] [3] [4] [5] [1] [5]"}
{"id": "article-31428_4", "title": "Wyburn-Mason Syndrome -- Etiology", "content": "Wyburn-Mason syndrome is\u00a0a congenital, nonhereditary, sporadic disorder. The precise risk factors associated with this condition are presently unknown\u00a0and some anomaly in the organogenesis is explained to be the etiology. An embryonic defect is believed to result in the spread of vascular lesions from the cephalic origin along the route of migration before the actual migration of the vascular cells to their final destination.\u00a0The concept of cerebrofacial arteriovenous metameric syndrome (CAMS)  is a classification system that describes the spectrum of phenotypical expression of AVM in the cerebral, orbital, and facial region. There are 3 types of CAMS. CAMS1 involves corpus callosum, hypothalamus, olfactory tract, forehead, and nose.\u00a0CAMS2 involves cortex and diencephalon, optic chiasma, optic nerve, retina, sphenoid, maxilla, and cheek. Wyburn-Mason syndrome has been\u00a0named\u00a0as CAMS2 according to this system of classification.\u00a0CAMS3\u00a0involves the cerebellum, temporal bone, and mandible. [5] [6] [7] [8] [1] [8]", "contents": "Wyburn-Mason Syndrome -- Etiology. Wyburn-Mason syndrome is\u00a0a congenital, nonhereditary, sporadic disorder. The precise risk factors associated with this condition are presently unknown\u00a0and some anomaly in the organogenesis is explained to be the etiology. An embryonic defect is believed to result in the spread of vascular lesions from the cephalic origin along the route of migration before the actual migration of the vascular cells to their final destination.\u00a0The concept of cerebrofacial arteriovenous metameric syndrome (CAMS)  is a classification system that describes the spectrum of phenotypical expression of AVM in the cerebral, orbital, and facial region. There are 3 types of CAMS. CAMS1 involves corpus callosum, hypothalamus, olfactory tract, forehead, and nose.\u00a0CAMS2 involves cortex and diencephalon, optic chiasma, optic nerve, retina, sphenoid, maxilla, and cheek. Wyburn-Mason syndrome has been\u00a0named\u00a0as CAMS2 according to this system of classification.\u00a0CAMS3\u00a0involves the cerebellum, temporal bone, and mandible. [5] [6] [7] [8] [1] [8]"}
{"id": "article-31428_5", "title": "Wyburn-Mason Syndrome -- Epidemiology", "content": "Wyburn-Mason is extremely uncommon\u00a0and\u00a0less than 100 cases have been reported in the literature.\u00a0There is no known gender or racial predilection. It is estimated that 30% of the patients with the retinal findings have brain findings and 8% of the patients with brain findings have retinal findings. [1]", "contents": "Wyburn-Mason Syndrome -- Epidemiology. Wyburn-Mason is extremely uncommon\u00a0and\u00a0less than 100 cases have been reported in the literature.\u00a0There is no known gender or racial predilection. It is estimated that 30% of the patients with the retinal findings have brain findings and 8% of the patients with brain findings have retinal findings. [1]"}
{"id": "article-31428_6", "title": "Wyburn-Mason Syndrome -- Epidemiology", "content": "Large retinal arteriovenous malformations, which cause visual or neurologic impairment usually are diagnosed in early life. Smaller arteriovenous malformations\u00a0may remain asymptomatic or be diagnosed only in later life.", "contents": "Wyburn-Mason Syndrome -- Epidemiology. Large retinal arteriovenous malformations, which cause visual or neurologic impairment usually are diagnosed in early life. Smaller arteriovenous malformations\u00a0may remain asymptomatic or be diagnosed only in later life."}
{"id": "article-31428_7", "title": "Wyburn-Mason Syndrome -- Pathophysiology", "content": "AVM in WMS is typically in the midbrain and ipsilateral retina. Vision loss from Wyburn-Mason syndrome\u00a0occurs secondary to the\u00a0presence and location of the arteriovenous malformations\u00a0in the retina or the orbit.\u00a0The tortuosity of AVM may increase over time which can cause obscuration of the visual centers, choroidal infarctions, retina ischemia, or by causing compression of the optic nerve or retinal vascular occlusions. These high-flow arteriovenous malformations\u00a0usually do not bleed or cause exudation in the retina.\u00a0However, intracranial AVMs can bleed. [9] Sometimes, there can be exudation and edema associated with retinal AVM. The proposed mechanisms of this edema include leakage from capillaries near the AVMs and pressure changes along the capillaries. [10] [11]", "contents": "Wyburn-Mason Syndrome -- Pathophysiology. AVM in WMS is typically in the midbrain and ipsilateral retina. Vision loss from Wyburn-Mason syndrome\u00a0occurs secondary to the\u00a0presence and location of the arteriovenous malformations\u00a0in the retina or the orbit.\u00a0The tortuosity of AVM may increase over time which can cause obscuration of the visual centers, choroidal infarctions, retina ischemia, or by causing compression of the optic nerve or retinal vascular occlusions. These high-flow arteriovenous malformations\u00a0usually do not bleed or cause exudation in the retina.\u00a0However, intracranial AVMs can bleed. [9] Sometimes, there can be exudation and edema associated with retinal AVM. The proposed mechanisms of this edema include leakage from capillaries near the AVMs and pressure changes along the capillaries. [10] [11]"}
{"id": "article-31428_8", "title": "Wyburn-Mason Syndrome -- History and Physical", "content": "Wyburn-Mason syndrome presents with a range of neurological symptoms that primarily depend on the location and size of the arteriovenous malformations. Neurological symptoms may include seizures, headaches, hemiparesis, visual deficits, cranial neuropathies, and hydrocephalus. [1] Arteriovenous malformations\u00a0located outside the central nervous system (CNS) may present with hematuria, hemoptysis, epistaxis, or frank bleeding. WMS usually affects one eye, though bilateral involvement has been infrequently reported. [2] Small arteriovenous malformations\u00a0within the eye may cause no visual symptoms. Large arteriovenous malformations\u00a0can produce severe vision loss. Eye problems can include blepharoptosis, proptosis, ocular motility disorders, retinal hemorrhages, vitreous hemorrhages, retinal detachments, vein occlusions (which can be complicated by associated rubeosis iridis and secondary glaucoma), optic disc edema, and optic atrophy.\u00a0Orbital AVMs can present with pulsatile proptosis\u00a0and\u00a0can have an accompanying bruit.", "contents": "Wyburn-Mason Syndrome -- History and Physical. Wyburn-Mason syndrome presents with a range of neurological symptoms that primarily depend on the location and size of the arteriovenous malformations. Neurological symptoms may include seizures, headaches, hemiparesis, visual deficits, cranial neuropathies, and hydrocephalus. [1] Arteriovenous malformations\u00a0located outside the central nervous system (CNS) may present with hematuria, hemoptysis, epistaxis, or frank bleeding. WMS usually affects one eye, though bilateral involvement has been infrequently reported. [2] Small arteriovenous malformations\u00a0within the eye may cause no visual symptoms. Large arteriovenous malformations\u00a0can produce severe vision loss. Eye problems can include blepharoptosis, proptosis, ocular motility disorders, retinal hemorrhages, vitreous hemorrhages, retinal detachments, vein occlusions (which can be complicated by associated rubeosis iridis and secondary glaucoma), optic disc edema, and optic atrophy.\u00a0Orbital AVMs can present with pulsatile proptosis\u00a0and\u00a0can have an accompanying bruit."}
{"id": "article-31428_9", "title": "Wyburn-Mason Syndrome -- History and Physical", "content": "The majority of individuals have involvement of the eye at a young age and can be severely visually impaired. If the\u00a0arteriovenous malformations are diagnosed at an early age, the risk of systemic involvement is high.", "contents": "Wyburn-Mason Syndrome -- History and Physical. The majority of individuals have involvement of the eye at a young age and can be severely visually impaired. If the\u00a0arteriovenous malformations are diagnosed at an early age, the risk of systemic involvement is high."}
{"id": "article-31428_10", "title": "Wyburn-Mason Syndrome -- Evaluation", "content": "The diagnosis of Wyburn-Mason syndrome is made on clinical examination. Retinal arteriovenous malformations\u00a0are usually diagnosed by ophthalmoscopy although fluorescein angiography may be required to demonstrate smaller lesions. Most arteriovenous malformations do not leak on angiography. Ultrasound and optical coherence tomography\u00a0(OCT)\u00a0can also confirm the diagnosis and be used to follow changes in the nerve fiber layer, macula, and retina over time.\u00a0OCT is very useful for the diagnosis of associated macular edema and serous retinal detachment.\u00a0Exophthalmometry is needed for the grading of proptosis if proptosis is present. Intracranial arteriovenous malformations\u00a0can be diagnosed with computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), or cerebral arteriography. Catheter angiography can demonstrate the size, location, and characteristics of the feeding arteries and draining veins and is felt to be the best method to analyze the exact angioarchitecture of the lesion.\u00a0Lesions have been reported in the skin but are very uncommon. CNS vascular lesions are typically on the same side as the involved eye. Central nervous system\u00a0vascular lesions often involve the midbrain.", "contents": "Wyburn-Mason Syndrome -- Evaluation. The diagnosis of Wyburn-Mason syndrome is made on clinical examination. Retinal arteriovenous malformations\u00a0are usually diagnosed by ophthalmoscopy although fluorescein angiography may be required to demonstrate smaller lesions. Most arteriovenous malformations do not leak on angiography. Ultrasound and optical coherence tomography\u00a0(OCT)\u00a0can also confirm the diagnosis and be used to follow changes in the nerve fiber layer, macula, and retina over time.\u00a0OCT is very useful for the diagnosis of associated macular edema and serous retinal detachment.\u00a0Exophthalmometry is needed for the grading of proptosis if proptosis is present. Intracranial arteriovenous malformations\u00a0can be diagnosed with computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), or cerebral arteriography. Catheter angiography can demonstrate the size, location, and characteristics of the feeding arteries and draining veins and is felt to be the best method to analyze the exact angioarchitecture of the lesion.\u00a0Lesions have been reported in the skin but are very uncommon. CNS vascular lesions are typically on the same side as the involved eye. Central nervous system\u00a0vascular lesions often involve the midbrain."}
{"id": "article-31428_11", "title": "Wyburn-Mason Syndrome -- Treatment / Management", "content": "Once there is a diagnosis of Wyburn-Mason syndrome, the treatment is\u00a0based on the location of the arteriovenous malformations\u00a0and the corresponding symptoms. Unruptured arteriovenous malformations without symptoms should be observed. Other options include radiation therapy, embolization, surgical resection, or a combination of these approaches. Intracranial AVM s should be approached as if it is having a risk of rupture of 2.2% per year. [12] Since intracranial surgeries are having increased risk of complications, observation and conservative management are advised in patients having mild symptoms e.g mild proptosis or mild ptosis.", "contents": "Wyburn-Mason Syndrome -- Treatment / Management. Once there is a diagnosis of Wyburn-Mason syndrome, the treatment is\u00a0based on the location of the arteriovenous malformations\u00a0and the corresponding symptoms. Unruptured arteriovenous malformations without symptoms should be observed. Other options include radiation therapy, embolization, surgical resection, or a combination of these approaches. Intracranial AVM s should be approached as if it is having a risk of rupture of 2.2% per year. [12] Since intracranial surgeries are having increased risk of complications, observation and conservative management are advised in patients having mild symptoms e.g mild proptosis or mild ptosis."}
{"id": "article-31428_12", "title": "Wyburn-Mason Syndrome -- Treatment / Management", "content": "Most retinal arteriovenous malformations\u00a0do not bleed externally but can produce minute hemorrhages that affect vision. Because of the stability of retinal lesions, ophthalmologists often serve to mainly diagnose Wyburn-Mason, obtain neuroimaging, organize systemic referrals, and perform periodic ophthalmologic assessments. However, complications arising from retinal AVMs need treatment. Patients who develop neovascular glaucoma require\u00a0retinal photocoagulation\u00a0to treat retinal ischemia. Pars plana vitrectomy may be done for non-clearing vitreous hemorrhage, and cyclodestructive procedures may be required to treat painful blind eyes with raised intraocular pressure resulting form neovascular glaucoma. [13] [14] Macular edema has been successfully managed with intravitreal injection of anti-VEGF agents in recent times. [2] [14]", "contents": "Wyburn-Mason Syndrome -- Treatment / Management. Most retinal arteriovenous malformations\u00a0do not bleed externally but can produce minute hemorrhages that affect vision. Because of the stability of retinal lesions, ophthalmologists often serve to mainly diagnose Wyburn-Mason, obtain neuroimaging, organize systemic referrals, and perform periodic ophthalmologic assessments. However, complications arising from retinal AVMs need treatment. Patients who develop neovascular glaucoma require\u00a0retinal photocoagulation\u00a0to treat retinal ischemia. Pars plana vitrectomy may be done for non-clearing vitreous hemorrhage, and cyclodestructive procedures may be required to treat painful blind eyes with raised intraocular pressure resulting form neovascular glaucoma. [13] [14] Macular edema has been successfully managed with intravitreal injection of anti-VEGF agents in recent times. [2] [14]"}
{"id": "article-31428_13", "title": "Wyburn-Mason Syndrome -- Differential Diagnosis", "content": "The differential diagnosis of WMS includes Von Hippel Lindau syndrome, vasoproliferative tumors (VPT), Sturge Weber syndrome, and retinal cavernous hemangioma.", "contents": "Wyburn-Mason Syndrome -- Differential Diagnosis. The differential diagnosis of WMS includes Von Hippel Lindau syndrome, vasoproliferative tumors (VPT), Sturge Weber syndrome, and retinal cavernous hemangioma."}
{"id": "article-31428_14", "title": "Wyburn-Mason Syndrome -- Differential Diagnosis", "content": "Von Hippel-Lindau disease is associated with\u00a0retinal capillary hemangioma (RCH), cerebral aneurysm, renal cell carcinoma, pheochromocytoma, and thus, should be considered as a differential diagnosis to decrease the risk of complications including the risk of death.\u00a0Clinically RCH appears as a round, circumscribed, orange to a red retinal lesion in the peripapillary or peripheral location. The RCH is associated with a prominent feeder vessel. [9] Abdominal radiological tests need to evaluate the kidneys. VHL is inherited in an autosomal dominant fashion, unlike WMS which is nonhereditary.", "contents": "Wyburn-Mason Syndrome -- Differential Diagnosis. Von Hippel-Lindau disease is associated with\u00a0retinal capillary hemangioma (RCH), cerebral aneurysm, renal cell carcinoma, pheochromocytoma, and thus, should be considered as a differential diagnosis to decrease the risk of complications including the risk of death.\u00a0Clinically RCH appears as a round, circumscribed, orange to a red retinal lesion in the peripapillary or peripheral location. The RCH is associated with a prominent feeder vessel. [9] Abdominal radiological tests need to evaluate the kidneys. VHL is inherited in an autosomal dominant fashion, unlike WMS which is nonhereditary."}
{"id": "article-31428_15", "title": "Wyburn-Mason Syndrome -- Differential Diagnosis", "content": "Vasoproliferative tumor is characterized by retinal nodules composed of glial cells interlaced with a fine capillary network and dilated hyalinised blood vessels. [15] VPT can be primary or secondary to retinal conditions like retinitis pigmentosa, coat\u2019s disease, and post-vitreoretinal surgery. Cryotherapy is used for exudative retinal detachment in VPT. [15]", "contents": "Wyburn-Mason Syndrome -- Differential Diagnosis. Vasoproliferative tumor is characterized by retinal nodules composed of glial cells interlaced with a fine capillary network and dilated hyalinised blood vessels. [15] VPT can be primary or secondary to retinal conditions like retinitis pigmentosa, coat\u2019s disease, and post-vitreoretinal surgery. Cryotherapy is used for exudative retinal detachment in VPT. [15]"}
{"id": "article-31428_16", "title": "Wyburn-Mason Syndrome -- Differential Diagnosis", "content": "Sturge-Weber syndrome should be considered if there are port-wine stains (facial angioma) or ipsilateral juvenile or congenital open-angle glaucoma. Hemangiomas of the meninges are found in Sturge-Weber syndrome.", "contents": "Wyburn-Mason Syndrome -- Differential Diagnosis. Sturge-Weber syndrome should be considered if there are port-wine stains (facial angioma) or ipsilateral juvenile or congenital open-angle glaucoma. Hemangiomas of the meninges are found in Sturge-Weber syndrome."}
{"id": "article-31428_17", "title": "Wyburn-Mason Syndrome -- Differential Diagnosis", "content": "Retinal cavernous hemangioma appears as a dark grape-like cluster of venous intraretinal aneurysms. The characteristic FFA finding is hypofluorescence till the late phase with a slow nonleaking filling of the aneurysms. [9]", "contents": "Wyburn-Mason Syndrome -- Differential Diagnosis. Retinal cavernous hemangioma appears as a dark grape-like cluster of venous intraretinal aneurysms. The characteristic FFA finding is hypofluorescence till the late phase with a slow nonleaking filling of the aneurysms. [9]"}
{"id": "article-31428_18", "title": "Wyburn-Mason Syndrome -- Staging", "content": "Archer et al. classified retinal\u00a0arteriovenous malformations into 3 groups: [16] Group 1 consists of retinal AVM consisting of a major artery and vein with an abnormal capillary network. These are small arteriole-venule anastomoses which can be subtle and difficult to detect clinically. These are stationary and rarely cause visual symptoms. Group 2 consists of retinal AVM between an artery and vein without a capillary network with the marked hyperdynamic flow in between the AVM. Vision may be affected if macular edema or hemorrhage resulting from the breakdown of blood-retinal barrier or venous thrombosis.", "contents": "Wyburn-Mason Syndrome -- Staging. Archer et al. classified retinal\u00a0arteriovenous malformations into 3 groups: [16] Group 1 consists of retinal AVM consisting of a major artery and vein with an abnormal capillary network. These are small arteriole-venule anastomoses which can be subtle and difficult to detect clinically. These are stationary and rarely cause visual symptoms. Group 2 consists of retinal AVM between an artery and vein without a capillary network with the marked hyperdynamic flow in between the AVM. Vision may be affected if macular edema or hemorrhage resulting from the breakdown of blood-retinal barrier or venous thrombosis."}
{"id": "article-31428_19", "title": "Wyburn-Mason Syndrome -- Staging", "content": "Group 3 consists of markedly convoluted, dilated, tortuous retinal vessels without a capillary network in between and presence of retinal disorganization. It can be nearly impossible to separate arteries from veins. These eyes usually have severe vision loss\u00a0and more likely to have intracranial malformations. These patients are usually diagnosed in childhood, and they have a higher risk of systemic vascular involvement.", "contents": "Wyburn-Mason Syndrome -- Staging. Group 3 consists of markedly convoluted, dilated, tortuous retinal vessels without a capillary network in between and presence of retinal disorganization. It can be nearly impossible to separate arteries from veins. These eyes usually have severe vision loss\u00a0and more likely to have intracranial malformations. These patients are usually diagnosed in childhood, and they have a higher risk of systemic vascular involvement."}
{"id": "article-31428_20", "title": "Wyburn-Mason Syndrome -- Prognosis", "content": "The natural history of WMS is unknown and the management is controversial. Hence, the prognosis of WMS is uncertain.", "contents": "Wyburn-Mason Syndrome -- Prognosis. The natural history of WMS is unknown and the management is controversial. Hence, the prognosis of WMS is uncertain."}
{"id": "article-31428_21", "title": "Wyburn-Mason Syndrome -- Prognosis", "content": "Patients of WMS may remain asymptomatic both visually and systemically. However, the prognosis of visually symptomatic patients depends upon the complications causing visual symptoms. Macular edema due to exudation from the AVM can be managed with intravitreal-anti-VEGF injections. Nonclearing VH can be managed with pars plana vitrectomy. Neovascular glaucoma can be managed with retinal photocoagulation and pressure-lowering therapies. However, the prognosis remains guarded mostly. The involvement of maxillofacial or mandibular vessels can lead to excessive hemorrhages during dental procedures.\u00a0The treating dentist or surgeon should be aware of this potential complication.", "contents": "Wyburn-Mason Syndrome -- Prognosis. Patients of WMS may remain asymptomatic both visually and systemically. However, the prognosis of visually symptomatic patients depends upon the complications causing visual symptoms. Macular edema due to exudation from the AVM can be managed with intravitreal-anti-VEGF injections. Nonclearing VH can be managed with pars plana vitrectomy. Neovascular glaucoma can be managed with retinal photocoagulation and pressure-lowering therapies. However, the prognosis remains guarded mostly. The involvement of maxillofacial or mandibular vessels can lead to excessive hemorrhages during dental procedures.\u00a0The treating dentist or surgeon should be aware of this potential complication."}
{"id": "article-31428_22", "title": "Wyburn-Mason Syndrome -- Prognosis", "content": "Intracranial surgeries for AVM remains largely controversial. A few reports of good outcome has been mentioned in patients with intracranial hemorrhage due to AVM. [17] [18] However, surgical resection of AVM located in the suprasellar and chiasmal location may place the vision and visual field in jeopardy. [19] [20] Many surgeons opt to treat these intracranial AVMs conservatively. [20] [17]", "contents": "Wyburn-Mason Syndrome -- Prognosis. Intracranial surgeries for AVM remains largely controversial. A few reports of good outcome has been mentioned in patients with intracranial hemorrhage due to AVM. [17] [18] However, surgical resection of AVM located in the suprasellar and chiasmal location may place the vision and visual field in jeopardy. [19] [20] Many surgeons opt to treat these intracranial AVMs conservatively. [20] [17]"}
{"id": "article-31428_23", "title": "Wyburn-Mason Syndrome -- Complications", "content": "Complications related to AVM can be intracranial hemorrhage or mechanical pressure-related damage. Ophthalmic complications include exudation from the AVM causing macular edema, retinal ischemia, retinal vein occlusion, neovascular glaucoma, and vitreous hemorrhage. The complications related to intracranial surgery include loss of vision or field of vision. Complications of dental or maxillary surgical procedures may include profuse bleeding due to the presence of these AVM.", "contents": "Wyburn-Mason Syndrome -- Complications. Complications related to AVM can be intracranial hemorrhage or mechanical pressure-related damage. Ophthalmic complications include exudation from the AVM causing macular edema, retinal ischemia, retinal vein occlusion, neovascular glaucoma, and vitreous hemorrhage. The complications related to intracranial surgery include loss of vision or field of vision. Complications of dental or maxillary surgical procedures may include profuse bleeding due to the presence of these AVM."}
{"id": "article-31428_24", "title": "Wyburn-Mason Syndrome -- Deterrence and Patient Education", "content": "The patients of WMS should be explained about the periodic check-up to rule out any early complications of the AVM.", "contents": "Wyburn-Mason Syndrome -- Deterrence and Patient Education. The patients of WMS should be explained about the periodic check-up to rule out any early complications of the AVM."}
{"id": "article-31428_25", "title": "Wyburn-Mason Syndrome -- Deterrence and Patient Education", "content": "Intracranial surgeries should be a reserved option for a few patients only e.g those with hemorrhage due to AVM or severe vision loss in one eye. [18] Intracranial surgeries are better to be avoided in asymptomatic and minimally symptomatic patients.", "contents": "Wyburn-Mason Syndrome -- Deterrence and Patient Education. Intracranial surgeries should be a reserved option for a few patients only e.g those with hemorrhage due to AVM or severe vision loss in one eye. [18] Intracranial surgeries are better to be avoided in asymptomatic and minimally symptomatic patients."}
{"id": "article-31428_26", "title": "Wyburn-Mason Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Once there is a diagnosis of Wyburn-Mason syndrome, the treatment is\u00a0based on the location of the arteriovenous malformations\u00a0and the corresponding symptoms. Because the condition is associated with high morbidity and mortality linked to hemorrhage, the disorder is best managed by an interprofessional team that includes an internist, geneticist, hematologist, radiologist, ophthalmologist, neurosurgeon,\u00a0and intensivist.\u00a0Dental surgeons and otorhinolaryngologists should be cautioned about the increased risk of hemorrhage for any interventional procedure that they plan to do.\u00a0Even during simple tooth extraction, significant hemorrhage can occur. Follow up is usually done by the primary care provider and nurse practitioner.\u00a0 Patients with unruptured arteriovenous malformations without symptoms can be observed; other options include radiation therapy, embolization, surgical resection, or a combination of these approaches. Before the patient undergoes any invasive procedure, the healthcare professional should be familiar with the syndrome and how to manage the hemorrhage. The outcomes for patients with eye involvement are guarded; most patients do end up with some degree of vision loss. [21] (Level V)", "contents": "Wyburn-Mason Syndrome -- Enhancing Healthcare Team Outcomes. Once there is a diagnosis of Wyburn-Mason syndrome, the treatment is\u00a0based on the location of the arteriovenous malformations\u00a0and the corresponding symptoms. Because the condition is associated with high morbidity and mortality linked to hemorrhage, the disorder is best managed by an interprofessional team that includes an internist, geneticist, hematologist, radiologist, ophthalmologist, neurosurgeon,\u00a0and intensivist.\u00a0Dental surgeons and otorhinolaryngologists should be cautioned about the increased risk of hemorrhage for any interventional procedure that they plan to do.\u00a0Even during simple tooth extraction, significant hemorrhage can occur. Follow up is usually done by the primary care provider and nurse practitioner.\u00a0 Patients with unruptured arteriovenous malformations without symptoms can be observed; other options include radiation therapy, embolization, surgical resection, or a combination of these approaches. Before the patient undergoes any invasive procedure, the healthcare professional should be familiar with the syndrome and how to manage the hemorrhage. The outcomes for patients with eye involvement are guarded; most patients do end up with some degree of vision loss. [21] (Level V)"}
{"id": "article-31428_27", "title": "Wyburn-Mason Syndrome -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Wyburn-Mason Syndrome -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}